Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 262

1.

Effect of Combined β-Lactam/Macrolide Therapy on Mortality According to the Microbial Etiology and Inflammatory Status of Patients with Community-Acquired Pneumonia.

Ceccato A, Cilloniz C, Martin-Loeches I, Ranzani OT, Gabarrus A, Bueno L, Garcia-Vidal C, Ferrer M, Niederman MS, Torres A.

Chest. 2018 Nov 22. pii: S0012-3692(18)32733-8. doi: 10.1016/j.chest.2018.11.006. [Epub ahead of print]

PMID:
30471269
2.

Respiratory Infections: An Ongoing Challenge with a Promising Future.

Niederman MS.

Clin Chest Med. 2018 Dec;39(4):xv-xvi. doi: 10.1016/j.ccm.2018.09.001. No abstract available.

PMID:
30390756
3.

Beat around the bush for VA-LRTI.

Martin-Loeches I, Depuydt P, Niederman MS.

Intensive Care Med. 2018 Nov;44(11):1961-1963. doi: 10.1007/s00134-018-5281-y. Epub 2018 Oct 21. No abstract available.

PMID:
30343316
4.

Decreased relative risk of pneumococcal pneumonia during the last decade, a nested case-control study.

Luna CM, Pulido L, Niederman MS, Casey A, Burgos D, Leiva Agüero SD, Grosso A, Membriani E, Entrocassi AC, Rodríquez Fermepin M, Vay CA, Garcia S, Famiglietti A.

Pneumonia (Nathan). 2018 Sep 25;10:9. doi: 10.1186/s41479-018-0053-6. eCollection 2018.

5.

A Therapeutic Strategy for All Pneumonia Patients: A 3-Year Prospective Multicenter- Cohort Study Using Risk Factors for Multidrug Resistant Pathogens To Select Initial Empiric Therapy.

Maruyama T, Fujisawa T, Ishida T, Ito A, Oyamada Y, Fujimoto K, Yoshida M, Maeda H, Miyashita N, Nagai H, Imamura Y, Shime N, Suzuki S, Amishima M, Higa F, Kobayashi H, Suga S, Tsutsui K, Kohno S, Brito V, Niederman MS.

Clin Infect Dis. 2018 Aug 1. doi: 10.1093/cid/ciy631. [Epub ahead of print]

PMID:
30084884
6.

Antibiotic treatment of hospital-acquired pneumonia: is it different from ventilator-associated pneumonia?

Niederman MS.

Curr Opin Crit Care. 2018 Oct;24(5):353-360. doi: 10.1097/MCC.0000000000000531.

PMID:
30028739
7.

Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumonia.

Torres A, Niederman MS, Chastre J, Ewig S, Fernandez-Vandellos P, Hanberger H, Kollef M, Li Bassi G, Luna CM, Martin-Loeches I, Paiva JA, Read RC, Rigau D, François Timsit J, Welte T, Wunderink R.

ERJ Open Res. 2018 Jun 26;4(2). pii: 00028-2018. doi: 10.1183/23120541.00028-2018. eCollection 2018 Apr.

8.

Pneumonia Complicating COPD: Are Corticosteroids a Help or a Hindrance?

Niederman MS.

Chronic Obstr Pulm Dis. 2018 Jan 18;5(1):1-4. doi: 10.15326/jcopdf.5.1.2018.0162. No abstract available.

9.

Future Research Directions in Pneumonia. NHLBI Working Group Report.

Dela Cruz CS, Wunderink RG, Christiani DC, Cormier SA, Crothers K, Doerschuk CM, Evans SE, Goldstein DR, Khatri P, Kobzik L, Kolls JK, Levy BD, Metersky ML, Niederman MS, Nusrat R, Orihuela CJ, Peyrani P, Prince AS, Ramírez JA, Ridge KM, Sethi S, Suratt BT, Sznajder JI, Tsalik EL, Walkey AJ, Yende S, Aggarwal NR, Caler EV, Mizgerd JP.

Am J Respir Crit Care Med. 2018 Jul 15;198(2):256-263. doi: 10.1164/rccm.201801-0139WS.

PMID:
29546996
10.

Imaging for the Management of Community-Acquired Pneumonia: What to Do if the Chest Radiograph Is Clear.

Niederman MS.

Chest. 2018 Mar;153(3):583-585. doi: 10.1016/j.chest.2017.09.045. No abstract available.

PMID:
29519296
11.

Adjuvant therapies in critical care: steroids in community-acquired pneumonia.

Torres A, Ferrer M, Niederman MS.

Intensive Care Med. 2018 Apr;44(4):478-481. doi: 10.1007/s00134-017-4967-x. Epub 2017 Oct 25. No abstract available.

PMID:
29071427
12.

Multi-drug resistant organism infections in a medical ICU: Association to clinical features and impact upon outcome.

Magira EE, Islam S, Niederman MS.

Med Intensiva. 2018 May;42(4):225-234. doi: 10.1016/j.medin.2017.07.006. Epub 2017 Oct 13. English, Spanish.

13.

Evaluation of the 2016 Infectious Diseases Society of America/American Thoracic Society Guideline Criteria for Risk of Multidrug-Resistant Pathogens in Patients with Hospital-acquired and Ventilator-associated Pneumonia in the ICU.

Ekren PK, Ranzani OT, Ceccato A, Li Bassi G, Muñoz Conejero E, Ferrer M, Niederman MS, Torres A.

Am J Respir Crit Care Med. 2018 Mar 15;197(6):826-830. doi: 10.1164/rccm.201708-1717LE. No abstract available.

PMID:
28902529
14.
15.

Treatment with macrolides and glucocorticosteroids in severe community-acquired pneumonia: A post-hoc exploratory analysis of a randomized controlled trial.

Ceccato A, Cilloniz C, Ranzani OT, Menendez R, Agusti C, Gabarrus A, Ferrer M, Sibila O, Niederman MS, Torres A.

PLoS One. 2017 Jun 15;12(6):e0178022. doi: 10.1371/journal.pone.0178022. eCollection 2017.

16.

Using Ventilator-Associated Pneumonia Rates as a Health Care Quality Indicator: A Contentious Concept.

Nair GB, Niederman MS.

Semin Respir Crit Care Med. 2017 Jun;38(3):237-244. doi: 10.1055/s-0037-1602580. Epub 2017 Jun 4. Review.

PMID:
28578548
17.

The research agenda in VAP/HAP: next steps.

Niederman MS, Martin-Loeches I, Torres A.

Intensive Care Med. 2017 Sep;43(9):1389-1391. doi: 10.1007/s00134-017-4695-2. Epub 2017 Feb 14. No abstract available.

PMID:
28197677
18.

Antibiotic therapy prior to hospital admission is associated with reduced septic shock and need for mechanical ventilation in patients with community-acquired pneumonia.

Amaro R, Sellarés J, Polverino E, Cillóniz C, Ferrer M, Fernández-Barat L, Mensa J, Niederman MS, Torres A.

J Infect. 2017 May;74(5):442-449. doi: 10.1016/j.jinf.2017.01.009. Epub 2017 Jan 24.

PMID:
28130142
19.

Invasive Disease vs Urinary Antigen-Confirmed Pneumococcal Community-Acquired Pneumonia.

Ceccato A, Torres A, Cilloniz C, Amaro R, Gabarrus A, Polverino E, Prina E, Garcia-Vidal C, Muñoz-Conejero E, Mendez C, Cifuentes I, Puig de la Bella Casa J, Menendez R, Niederman MS.

Chest. 2017 Jun;151(6):1311-1319. doi: 10.1016/j.chest.2017.01.005. Epub 2017 Jan 16.

PMID:
28093269
20.

Principles of Antibiotic Management of Community-Acquired Pneumonia.

Bender MT, Niederman MS.

Semin Respir Crit Care Med. 2016 Dec;37(6):905-912. Epub 2016 Dec 13. Review.

PMID:
27960214
21.

Serum procalcitonin and the admission decision in CAP.

Niederman MS.

Lancet Respir Med. 2016 Dec;4(12):956. doi: 10.1016/S2213-2600(16)30383-6. Epub 2016 Nov 22. No abstract available.

PMID:
27890506
22.

The Impact of Age and Comorbidities on the Mortality of Patients of Different Age Groups Admitted with Community-acquired Pneumonia.

Luna CM, Palma I, Niederman MS, Membriani E, Giovini V, Wiemken TL, Peyrani P, Ramirez J.

Ann Am Thorac Soc. 2016 Sep;13(9):1519-26. doi: 10.1513/AnnalsATS.201512-848OC.

PMID:
27398827
23.

Lessons learned from 2 decades of CAP therapy data: ways to improve patient management.

Bender MT, Niederman MS.

J Thorac Dis. 2016 Jun;8(6):E455-9. doi: 10.21037/jtd.2016.04.36. No abstract available.

24.

Community-Acquired Pneumonia Due to Multidrug- and Non-Multidrug-Resistant Pseudomonas aeruginosa.

Cillóniz C, Gabarrús A, Ferrer M, Puig de la Bellacasa J, Rinaudo M, Mensa J, Niederman MS, Torres A.

Chest. 2016 Aug;150(2):415-25. doi: 10.1016/j.chest.2016.03.042. Epub 2016 Apr 7.

PMID:
27060725
25.

Understanding community-acquired respiratory tract infections: new concepts of disease pathogenesis and new management strategies.

Niederman MS, Zumla A.

Curr Opin Pulm Med. 2016 May;22(3):193-5. doi: 10.1097/MCP.0000000000000274. No abstract available.

PMID:
27035243
26.

What is Legionnaires' Disease?

Marion CR, Dela Cruz CS, Niederman MS.

Am J Respir Crit Care Med. 2016 Feb 15;193(4):P5-6. doi: 10.1164/rccm.1934P5. No abstract available.

PMID:
26871677
27.

Improving outcomes in community-acquired pneumonia.

Bender MT, Niederman MS.

Curr Opin Pulm Med. 2016 May;22(3):235-42. doi: 10.1097/MCP.0000000000000257. Review.

PMID:
26859379
28.

The road forward in the management of Acinetobacter infections in the ICU.

Niederman MS, Kollef MH.

Intensive Care Med. 2015 Dec;41(12):2207-9. No abstract available.

PMID:
26499480
29.

Why is Acinetobacter baumannii a problem for critically ill patients?

Kollef MH, Niederman MS.

Intensive Care Med. 2015 Dec;41(12):2170-2. No abstract available.

PMID:
26474995
30.

In the Clinic: Community-Acquired Pneumonia.

Niederman MS.

Ann Intern Med. 2015 Oct 6;163(7):ITC1-17. doi: 10.7326/AITC201510060. Review. No abstract available.

PMID:
26436631
31.

Real life management of community-acquired Pneumonia in adults in the Gulf region and comparison with practice guidelines: a prospective study.

Mahboub B, Al Zaabi A, Al Ali OM, Ahmed R, Niederman MS, El-Bishbishi R.

BMC Pulm Med. 2015 Sep 30;15:112. doi: 10.1186/s12890-015-0108-x.

32.

Outcomes and Prognostic Features of Patients With Influenza Requiring Hospitalization and Receiving Early Antiviral Therapy: A Prospective Multicenter Cohort Study.

Maruyama T, Fujisawa T, Suga S, Nakamura H, Nagao M, Taniguchi K, Tsutsui K, Ihara T, Niederman MS.

Chest. 2016 Feb;149(2):526-534. doi: 10.1378/chest.14-2768. Epub 2016 Jan 12.

PMID:
26203671
33.

Predictors of Clinical Success in the Treatment of Patients with Methicillin-Resistant Staphylococcus aureus (MRSA) Nosocomial Pneumonia (NP).

Shorr AF, Puzniak LA, Biswas P, Niederman MS.

PLoS One. 2015 Jul 21;10(7):e0131932. doi: 10.1371/journal.pone.0131932. eCollection 2015.

34.

Macrolide-Resistant Pneumococcus in Community-acquired Pneumonia. Is There Still a Role for Macrolide Therapy?

Niederman MS.

Am J Respir Crit Care Med. 2015 Jun 1;191(11):1216-7. doi: 10.1164/rccm.201504-0701ED. No abstract available.

PMID:
26029831
35.

Ventilator-associated pneumonia prevention: response to Silvestri et al.

Nair GB, Niederman MS.

Intensive Care Med. 2015 May;41(5):957. doi: 10.1007/s00134-015-3756-7. Epub 2015 Mar 31. No abstract available.

PMID:
25821904
36.

Respiratory tract infections in community and healthcare settings: epidemiological, diagnostic and management challenges.

Zumla A, Niederman MS.

Curr Opin Pulm Med. 2015 May;21(3):209-11. doi: 10.1097/MCP.0000000000000163. No abstract available.

PMID:
25784249
37.

Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial.

Torres A, Sibila O, Ferrer M, Polverino E, Menendez R, Mensa J, Gabarrús A, Sellarés J, Restrepo MI, Anzueto A, Niederman MS, Agustí C.

JAMA. 2015 Feb 17;313(7):677-86. doi: 10.1001/jama.2015.88.

38.

Year in review 2013: Critical Care--respiratory infections.

Nair GB, Niederman MS.

Crit Care. 2014 Oct 29;18(5):572. doi: 10.1186/s13054-014-0572-3. Review.

39.

Managing ventilator complications in a "VACuum" of data.

Niederman MS, Nair GB.

Chest. 2015 Jan;147(1):5-6. doi: 10.1378/chest.14-1496. No abstract available.

PMID:
25560851
40.

Ventilator-associated pneumonia: present understanding and ongoing debates.

Nair GB, Niederman MS.

Intensive Care Med. 2015 Jan;41(1):34-48. doi: 10.1007/s00134-014-3564-5. Epub 2014 Nov 27. Review.

PMID:
25427866
41.

An Economic Model to Compare the Different Empiric and First/Second Line Treatment Regimens for Suspected Methicillin-Resistant Staphylococcus Aureus Nosocomial Pneumonia.

Patel D, Niederman MS, Li JZ, Mcnamara R, Haider S, Stephens J.

Value Health. 2014 Nov;17(7):A674. doi: 10.1016/j.jval.2014.08.2499. Epub 2014 Oct 26. No abstract available.

42.

Health economic evaluation of patients treated for nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus: secondary analysis of a multicenter randomized clinical trial of vancomycin and linezolid.

Niederman MS, Chastre J, Solem CT, Wan Y, Gao X, Myers DE, Haider S, Li JZ, Stephens JM.

Clin Ther. 2014 Sep 1;36(9):1233-1243.e1. doi: 10.1016/j.clinthera.2014.06.029. Epub 2014 Jul 25.

PMID:
25066668
43.

Global prospective epidemiologic and surveillance study of ventilator-associated pneumonia due to Pseudomonas aeruginosa.

Kollef MH, Chastre J, Fagon JY, François B, Niederman MS, Rello J, Torres A, Vincent JL, Wunderink RG, Go KW, Rehm C.

Crit Care Med. 2014 Oct;42(10):2178-87. doi: 10.1097/CCM.0000000000000510.

PMID:
25054674
44.

Inhaled corticosteroids and systemic inflammatory response in community-acquired pneumonia: a prospective clinical study.

Ferrer M, Torres A, Martínez R, Ramírez P, Polverino E, Montull B, Sialer S, Niederman MS, Agusti A, Menéndez R.

Respirology. 2014 Aug;19(6):929-35. doi: 10.1111/resp.12324. Epub 2014 Jun 9.

45.

Response.

Luna CM, Sarquis S, Sosa A, Otaola M, Bailleau N, Vay CA, Irrarzábal C, Famiglietti A, Capdevila AA, Niederman MS.

Chest. 2014 Apr;145(4):925-6. doi: 10.1378/chest.13-2857. No abstract available.

PMID:
24687719
46.

Year in review 2012: Critical Care--respiratory infections.

Nair GB, Niederman MS.

Crit Care. 2013 Nov 22;17(6):251. doi: 10.1186/cc12773. Review.

47.

Reply to Yamamoto et al.

Niederman MS, Maruyama T, Fujisawa T.

Clin Infect Dis. 2014 Apr;58(7):1040-1. doi: 10.1093/cid/ciu016. Epub 2014 Jan 11. No abstract available.

PMID:
24415664
48.

A new strategy for healthcare-associated pneumonia: a 2-year prospective multicenter cohort study using risk factors for multidrug-resistant pathogens to select initial empiric therapy.

Maruyama T, Fujisawa T, Okuno M, Toyoshima H, Tsutsui K, Maeda H, Yuda H, Yoshida M, Kobayashi H, Taguchi O, Gabazza EC, Takei Y, Miyashita N, Ihara T, Brito V, Niederman MS.

Clin Infect Dis. 2013 Nov;57(10):1373-83. doi: 10.1093/cid/cit571. Epub 2013 Sep 2.

PMID:
23999080
49.

Telavancin versus vancomycin for bacteraemic hospital-acquired pneumonia.

Stryjewski ME, Barriere SL, Rubinstein E, Genter FC, Lentnek AL, Magana-Aquino M, Luna CM, Niederman MS, Torres A, Corey GR.

Int J Antimicrob Agents. 2013 Oct;42(4):367-9. doi: 10.1016/j.ijantimicag.2013.06.003. Epub 2013 Jul 26. No abstract available.

PMID:
23891527
50.

Nosocomial pneumonia: lessons learned.

Nair GB, Niederman MS.

Crit Care Clin. 2013 Jul;29(3):521-46. doi: 10.1016/j.ccc.2013.03.007. Epub 2013 Apr 30. Review.

PMID:
23830652

Supplemental Content

Loading ...
Support Center